Carfilzomib Is Safe and Effective in Newly Diagnosed Patients with Multiple Myeloma with Renal Involvement

被引：0
|
作者：
Diamond, Benjamin
Jayabalan, David S.
Pearse, Roger
Perry, Art
Pekle, Karen
Niesvizky, Ruben
Rossi, Adriana C.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3102
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The influencing factors of renal response in newly diagnosed multiple myeloma patients with renal impairment
    宋宇航
    ChinaMedicalAbstracts(InternalMedicine), 2023, 40 (02) : 119 - 119
  • [22] Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma
    Facon, Thierry
    Lee, Jae Hoon
    Moreau, Philippe
    Niesvizky, Ruben
    Dimopoulos, Meletios
    Hajek, Roman
    Pour, Ludek
    Jurczyszyn, Artur
    Qiu, Lugui
    Klippel, Zandra
    Zahlten-Kumeli, Anita
    Osman, Muhtarjan
    Paiva, Bruno
    San-Miguel, Jesus
    BLOOD, 2019, 133 (18) : 1953 - 1963
  • [23] Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma
    Siyang Leng
    Divaya Bhutani
    Shahzad Raza
    Amer Assal
    Samuel Pan
    Jianhua Hu
    Alexander Wei
    Markus Mapara
    Suzanne Lentzsch
    Blood Cancer Journal, 10
  • [24] BORTEZOMIB, MELPHALAN AND DEXAMETHASONE (VM-DEX) IS A SAFE AND EFFECTIVE THERAPY FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA
    Gozzetti, A.
    Defina, M.
    Bocchia, M.
    Fabbri, A.
    Marchini, E.
    Chitarrelli, I.
    Lauria, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 589 - 589
  • [25] Cardiac and renal complications of carfilzomib in patients with multiple myeloma
    Dimopoulos, Meletios A.
    Roussou, Maria
    Gavriatopoulou, Maria
    Psimenou, Erasmia
    Ziogas, Dimitrios
    Eleutherakis-Papaiakovou, Evangelos
    Fotiou, Despina
    Migkou, Magdalini
    Kanellias, Nikolaos
    Panagiotidis, Ioannis
    Ntalianis, Argyrios
    Papadopoulou, Elektra
    Stamatelopoulos, Kimon
    Manios, Efstathios
    Pamboukas, Constantinos
    Kontogiannis, Sofoklis
    Terpos, Evangelos
    Kastritis, Efstathios
    BLOOD ADVANCES, 2017, 1 (07) : 449 - 454
  • [26] WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (WKCYD) FOLLOWED BY MAINTENANCE WITH WEEKLY CARFILZOMIB (WK) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
    Bringhen, S.
    De Paoli, L.
    Larocca, A.
    Ballanti, S.
    Gentilini, F.
    Liberati, A. M.
    Passera, R.
    Bernardini, A.
    Esma, F.
    Galieni, P.
    Offidani, M.
    Corradini, P.
    Gaidano, G.
    Boccadoro, M.
    Sonneveld, P.
    Palumbo, A.
    HAEMATOLOGICA, 2016, 101 : 2 - 2
  • [27] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [28] Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment
    Jian, Yuan
    Chang, Long
    Shi, Ming-Xia
    Sun, Ying
    Chu, Xiao-Xia
    Xue, Hua
    Huang, Wen-Rong
    Shen, Xu-Liang
    Ma, Jie
    Jia, Guo-Rong
    Feng, Ya-Qing
    Xi, Zhen-Fang
    Zhao, Yan-Hong
    Ma, Yan-Ping
    Xiao, Jing
    Ma, Guang-Yu
    Wang, Qing-Ming
    Bao, Li
    Dong, Yu-Jun
    Zhou, He-Bing
    Sun, Chun-Yan
    Su, Guo-Hong
    Yan, Yan
    Qimuge, Sai-Yin
    Su, Li-Ping
    Sun, Jing-Nan
    Tian, Wei-Wei
    Sun, Xiu-Li
    Ing, Hong-Mei
    Gao, Da
    Chen, Wen-Ming
    Li, Jian
    Gao, Wen
    BLOOD ADVANCES, 2023, 7 (24) : 7581 - 7584
  • [29] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    Blood Cancer Journal, 9
  • [30] Renal Outcomes and Predictive Analysis of Progression in Newly Diagnosed Multiple Myeloma Patients
    Lalwani, Devansh
    Khan, Hamza
    Nair, Aditya
    Mishra, Dhyey
    Shah, Jash
    Nabar, Leeladhar
    Talati, Shriraj
    Tembhare, Prashant
    Nayak, Lingaraj
    Shetty, Alok
    Rajpal, Sweta
    Chatterjee, Gaurav
    Khan, Ajmat
    Mirgh, Sumeet
    Jindal, Nishant
    Gokarn, Anant
    Punatar, Sachin
    Jain, Hasmukh
    Patkar, Nikhil
    Shetty, Dhanlaxmi
    Subramanian, Papagudi
    Gujral, Sumeet
    Bagal, Bhausaheb
    Sengar, Manju
    Khattry, Navin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S233 - S234
12345